In a new report by Quartz Advisor, data shows that since 2016, traffic fatalities fell in four states that legalized adult-use cannabis, with a slight increase of fatalities in five states that have not legalized cannabis. The report showed some anomalies, however, and there was a slight increase of... Read more
Friday, Oct. 27 was a historic day for cannabis in Georgia and throughout the country, as it was the first day that pharmacists were legally allowed to sell cannabis at the pharmacy counter. Dr. Ankit Patel was the first pharmacist to begin selling cannabis at his pharmacy, Robins Pharmacy.... Read more
Meta Platforms Inc., aka Mark Zuckerberg’s tech giant behind social media giants like Facebook and Instagram, has chosen to ignore advice from its ethics watchdog regarding how the platform manages posts connected to psychedelics. The drama dates back to a 2022 “paid partner” post that promoted a ketamine treatment... Read more
A major supplier of drug testing kits has announced an updated screening panel which no longer tests for cannabis and prioritizes testing for fentanyl. Psychemedics, a Massachusetts-based producer of drug testing kits announced Friday that they would be launching a new five-panel drug screen which will “ the spotlight... Read more
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, We... Read more
The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. This update is our first since late August, and there will be many financial releases very soon. Tracker Rules This data-driven, fact-based tracker will continually update based on new financial... Read more
For the first time, a psilocybin mushroom license was granted in New Zealand, marking a major milestone in a Māori health science. The effort was led by Rangiwaho marae, based south of Gisborne in New Zealand. According to an Oct. 26 joint media release, Rua Bioscience, a biopharmaceutical business... Read more
Switzerland will allow Europe’s first non-medical cannabis dispensaries to open and operate as part of a study to examine how controlled access to legal cannabis may affect health and consumption patterns of regular cannabis consumers. An announcement was made Friday about “Grashaus Projects” by German CBD and cannabinoid research... Read more
A survey, released this week by the cannabis wellness company EO Care, found that “18 percent of respondents have used cannabis for health reasons in the past year, 19 percent have used cannabis for recreational reasons, and 14 percent have used it for both.” It also revealed that the... Read more
As states throughout the country continue to legalize medical and adult-use cannabis, the federal de-scheduling and later legalization of cannabis is likely to come sometime in the near future. But what exactly comes with such a widespread shift in policy? As we look ahead at the potential for federal... Read more
